Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas

Transcription factor NRF2 orchestrates a cellular defense against oxidative stress and, so far, has been involved in tumor progression by providing a metabolic adaptation to tumorigenic demands and resistance to chemotherapeutics. In this study, we discover that NRF2 also propels tumorigenesis in gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Escoll, Maribel, Lastra, Diego, Pajares, Marta, Robledinos-Antón, Natalia, Rojo, Ana I., Fernández-Ginés, Raquel, Mendiola, Marta, Martínez-Marín, Virginia, Esteban, Isabel, López-Larrubia, Pilar, Gargini, Ricardo, Cuadrado, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016245/
https://www.ncbi.nlm.nih.gov/pubmed/31918259
http://dx.doi.org/10.1016/j.redox.2019.101425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016245/
https://www.ncbi.nlm.nih.gov/pubmed/31918259
http://dx.doi.org/10.1016/j.redox.2019.101425

Ejemplares similares